GIUGGIOLI, DILIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 30.062
EU - Europa 17.153
AS - Asia 14.850
SA - Sud America 2.090
AF - Africa 387
OC - Oceania 42
Continente sconosciuto - Info sul continente non disponibili 20
Totale 64.604
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 29.561
IT - Italia 6.246
SG - Singapore 4.681
GB - Regno Unito 4.675
CN - Cina 4.112
HK - Hong Kong 1.797
BR - Brasile 1.603
VN - Vietnam 1.490
SE - Svezia 1.236
DE - Germania 974
FI - Finlandia 887
FR - Francia 770
UA - Ucraina 601
RU - Federazione Russa 579
TR - Turchia 539
KR - Corea 538
IN - India 393
ID - Indonesia 294
NL - Olanda 240
BG - Bulgaria 233
CA - Canada 217
MX - Messico 187
AR - Argentina 186
JP - Giappone 154
BD - Bangladesh 144
ZA - Sudafrica 133
IQ - Iraq 97
IE - Irlanda 96
ES - Italia 92
AE - Emirati Arabi Uniti 85
PL - Polonia 85
PK - Pakistan 81
AT - Austria 65
EC - Ecuador 63
CO - Colombia 62
BE - Belgio 56
MY - Malesia 55
LT - Lituania 51
EG - Egitto 49
MA - Marocco 47
CL - Cile 44
SA - Arabia Saudita 44
TN - Tunisia 42
VE - Venezuela 42
RO - Romania 40
IR - Iran 38
PH - Filippine 38
AU - Australia 37
CZ - Repubblica Ceca 31
PE - Perù 31
CH - Svizzera 30
NP - Nepal 29
PY - Paraguay 29
TH - Thailandia 28
UZ - Uzbekistan 28
BZ - Belize 26
KE - Kenya 26
JO - Giordania 23
TW - Taiwan 23
AZ - Azerbaigian 19
AL - Albania 18
ET - Etiopia 17
HU - Ungheria 16
DZ - Algeria 15
OM - Oman 15
PT - Portogallo 15
BY - Bielorussia 14
GR - Grecia 14
IL - Israele 14
BO - Bolivia 13
EU - Europa 13
UY - Uruguay 13
CR - Costa Rica 12
DO - Repubblica Dominicana 12
LV - Lettonia 11
SN - Senegal 11
DK - Danimarca 10
KZ - Kazakistan 10
PS - Palestinian Territory 10
KG - Kirghizistan 9
BH - Bahrain 8
GE - Georgia 8
JM - Giamaica 8
NG - Nigeria 8
RS - Serbia 8
SY - Repubblica araba siriana 8
EE - Estonia 7
LU - Lussemburgo 7
MD - Moldavia 7
SI - Slovenia 7
HN - Honduras 6
HR - Croazia 6
NO - Norvegia 6
PA - Panama 6
QA - Qatar 6
SK - Slovacchia (Repubblica Slovacca) 6
AM - Armenia 5
AO - Angola 5
BA - Bosnia-Erzegovina 5
BB - Barbados 5
Totale 64.496
Salva come PNG Salva come JPEG
Città #
Southend 3.361
Santa Clara 3.065
Singapore 3.018
Fairfield 2.599
Ashburn 2.535
Hong Kong 1.771
Woodbridge 1.481
Hefei 1.420
Chandler 1.325
San Jose 1.255
Houston 1.210
Jacksonville 948
Seattle 938
Wilmington 914
Chicago 906
Cambridge 829
Los Angeles 752
Ann Arbor 740
London 686
Nyköping 679
Helsinki 668
Beijing 631
Dearborn 622
Seoul 501
Council Bluffs 496
Ho Chi Minh City 475
Milan 446
Salt Lake City 427
The Dalles 423
Modena 386
Rome 384
Hanoi 375
New York 357
Izmir 298
San Diego 287
Lauterbourg 253
Princeton 234
Sofia 224
Bologna 222
Jakarta 219
Tampa 196
Buffalo 175
Elk Grove Village 168
Dallas 163
Moscow 162
Eugene 157
São Paulo 155
Frankfurt am Main 151
Shanghai 149
Bremen 120
Florence 114
Atlanta 113
Naples 112
Orem 109
Redwood City 104
Des Moines 102
Tokyo 94
Munich 93
Columbus 91
Palermo 90
Guangzhou 85
Mexico City 83
Phoenix 83
Dublin 80
Sterling 80
Lancaster 76
Parma 71
Da Nang 70
Catania 68
Chennai 65
Kent 65
Warsaw 65
Bari 64
Johannesburg 64
Miami 63
Detroit 61
Denver 60
Falls Church 59
Haiphong 59
Turin 59
Montreal 58
Redondo Beach 54
Toronto 54
Genoa 52
Stockholm 51
Amsterdam 50
Norwalk 50
Dulles 49
Manchester 49
Boardman 48
Verona 48
Padova 47
Reggio Emilia 47
New Delhi 44
Ovada 43
Belo Horizonte 42
Lappeenranta 42
Nuremberg 42
Delhi 41
Brooklyn 40
Totale 43.309
Salva come PNG Salva come JPEG
Nome #
INTERSTIZIOPATIA POLMONARE NON CLASSIFICABILE O SECONDARIA A CONNETTIVITE INDIFFERENZIATA. IMPORTANZA E DIFFICOLTÀ DI UNA DIAGNOSI DIFFERENZIALE. 3.817
ALTERAZIONI CAPILLAROSCOPICHE IN CORSO DI DERMATOMIOSITE E SCLEROSI SISTEMICA; VERSO L’INDIVIDUAZIONE DI PATTERN SPECIFICI 935
HCV-unrelated cryoglobulinaemic vasculitis: the results of a prospective observational study by the Italian Group for the Study of Cryoglobulinaemias (GISC) 774
Thyroid Involvement in Hepatitis C Virus-Infected Patients with/without Mixed Cryoglobulinemia 758
Capillaroscopic skin ulcer risk index: a new prognostic tool for digital skin ulcer development in systemic sclerosis patients. 466
Evoluzione dello CSURI (Capillaroscopic Skin Ulcer Risk Index) in pazienti affetti da sclerosi sistemica in terapia con antiendotelina-1 e prostanoidi 444
Bronchoalveolar lavage and response to cyclophosphamide in scleroderma alveolitis. 428
Chemokine (C-X-C motif) ligand (CXCL)10 in autoimmune diseases. 423
Oxycodone in the Long-Term Treatment of Chronic Pain Related to Scleroderma Skin Ulcers. 419
Systemic sclerosis progression INvestiGation (SPRING) Italian registry: Demographic and clinico-serological features of the scleroderma spectrum 399
Thymus alterations and systemic sclerosis 383
Systemic sclerosis and cryoglobulinemia: our experience with overlapping syndrome of scleroderma and severe cryoglobulinemic vasculitis and review of the literature. 383
Effect of treatment with iloprost with or without bosentan on nailfold videocapillaroscopic alterations in patients with systemic sclerosis 372
Nailfold Videocapillaroscopy Alterations in Dermatomyositis and Systemic Sclerosis: Toward Identification of a Specific Pattern 369
D-penicillamine in the treatment of eosinophilic fasciitis: case reports and review of the literature. 368
Radiological thymus alterations in systemic sclerosis: our experience and a review of the literature. 368
Hepatitis C virus infection and type 1 and type 2 diabetes mellitus 366
Human parvovirus B19 experimental infection in human fibroblasts and endothelial cells cultures 357
Heart involvement and systemic sclerosis 355
CXCL10 (α) and CCL2 (β) chemokines in systemic sclerosis - A longitudinal study 348
Systemic sclerosis evolution of disease pathomorphosis and survival. Our experience on Italian patients' population and review of the literature 347
Mixed cryoglobulinemia: Demographic, clinical, and serologic features and survival in 231 patients 347
COVID-19 and rheumatic autoimmune systemic diseases: report of a large Italian patients series 344
Incidence of thyroid disorders in systemic sclerosis: results from a longitudinal follow-up. 342
Scleroderma digital ulcers complicated by infection with fecal pathogens. 340
Current treatment of hepatitis C-associated rheumatic diseases. 338
Carotidynia Possibly due to Localized Vasculitis in a Patient with Latent Mycobacterium tuberculosis Infection. 337
Aortic pulse wave velocity measurement in systemic sclerosis patients. 335
Breast cancer in systemic sclerosis: Results of a cross-linkage of an Italian Rheumatologic Center and a population-based Cancer Registry and review of the literature 333
Correlation of articular involvement, skin disfigurement, and unemployment with depressive symptoms in patients with systemic sclerosis: a hospital sample 331
Treatment of severe scleroderma skin ulcers with recombinant human erythropoietin 323
Chemokines in the pathogenesis and as therapeutical markers and targets of HCV chronic infection, and HCV extrahepatic manifestations 321
Elevated Troponin Serum Levels in Adult Onset Still's Disease 319
Thyroid involvement in patients with HCV-related mixed cryoglobulinaemia 319
Cardio-pulmonary disease management in patients with systemic sclerosis: cardio-rheumatology clinic and patient care standardisation proposal 319
Recombinant human erythropoietin stimulates vasculogenesis and wound healing in a patient with systemic sclerosis complicated by severe skin ulcers. 319
Established coronary artery disease in systemic sclerosis compared to type 2 diabetic female patients: a cross-sectional study 318
Serum 25-OH vitamin D levels in systemic sclerosis: analysis of 140 patients and review of the literature 317
L-Arginine in pregnant scleroderma patients 317
Cardiac involvement in systemic sclerosis: identification of high-risk patient profiles in different patterns of clinical presentation 316
Efficacia di terapia con immunoassorbimento con proteina A dello stafilococco e talidomide in un caso di dermatomiosite refrattaria. 313
Gynaecological Screening for Cervical and Vulvar Malignancies in a Cohort of Systemic Sclerosis Patients: Our Experience and Review of the Literature 309
Autoimmune and neoplastic thyroid diseases associated with hepatitis C chronic infection 308
Targeting chemokine (C-X-C motif) receptor 3 in thyroid autoimmunity 304
Unusual association between Budd–Chiari syndrome secondary to antiphospholipid syndrome and relapsing polychondritis: a case report and review of the literature 303
Platelet gel in the treatment of severe scleroderma skin ulcers. 302
Cryoglobulinemic vasculitis and skin ulcers. Our therapeutic strategy and review of the literature 300
Parvoviral infection of endothelial cells and stromal fibroblasts: a possible pathogenetic role in scleroderma 299
HCV and cryoglobulinemic vasculitis. 296
Antiendothelial cell antibodies induce apoptosis of bone marrow endothelial progenitors in systemic sclerosis 296
Nailfold capillaroscopic changes in dermatomyositis and polymyositis 295
Successful treatment with leflunomide of arthritis in systemic sclerosis patients 294
SAT0633-HPR Articular Involvement of the Scleroderma Hand: An Assessment Protocol for Planning Occupational Therapy Strategies 291
Lung cancer in scleroderma: results from an Italian rheumatologic center and review of the literature. 291
Predictive value of isolated DLCO reduction in systemic sclerosis patients without cardio-pulmonary involvement at baseline 289
Capillaroscopic Skin Ulcers Risk Index (CSURI) calculated with different videocapillaroscopy devices: how its predictive values change 284
Cardiovascular risk and prostanoids in systemic sclerosis 283
Long-term treatment with rituximab in interstitial lung disease related to systemic sclerosis: our clinical experience 280
Haematological Malignancies in Systemic Sclerosis Patients: Case Reports and Review of the World Literature 279
Brief report: successful pregnancies but a higher risk of preterm births in patients with systemic sclerosis: an Italian multicenter study 278
Prevalence and evolution of scleroderma pattern at nailfold videocapillaroscopy in systemic sclerosis patients: Clinical and prognostic implications 278
Interstitial pneumonia with autoimmune features and undifferentiated connective tissue disease: Our interdisciplinary rheumatology-pneumology experience, and review of the literature 277
Ultrasonography involvement of carotid, upper and lower limb arteries in a large cohort of systemic sclerosis patients 277
Associations between Systemic Sclerosis and Thyroid Diseases 276
Amlodipine in the treatment of Raynaud's phenomenon 274
Induction of CXCL10 secretion by interferon-γ and tumour necrosis factor-α and its inhibition by peroxisome proliferator-activated receptor-γ agonists in cultured scleroderma fibroblasts. 274
CORRELATION OF A QUANTITATIVE VIDEOCAPILLAROSCOPIC SCORE WITH THE DEVELOPMENT OF DIGITAL SKIN ULCERS IN SCLERODERMA PATIENTS 273
Polymyositis following Pandemic Influenza A (H1N1) and 2009-10 Seasonal Trivalent Vaccines 273
Autologous skin grafting in the treatment of severe scleroderma cutaneous ulcers: a case report 272
Application of Agents Against Interferon-Gamma-Dependent Chemokines in Immunotherapy 272
Management of cardiopulmonary disease in patients with systemic sclerosis: cardiorheumatology clinic and patient care standardization proposal 272
Prediction risk chart for scleroderma digital ulcers: A composite predictive model based on capillaroscopic, demographic and clinico-serological parameters 269
CAPILLAROSCOPIC SKIN ULCER RISK INDEX (CSURI) IN SYSTEMIC SCLEROSIS: RESULTS FROM AN ITALIAN MULTICENTER VALIDATION STUDY 262
The link between pain patient and analgesic medication is greater in migraine than in rheumatic disease patients 261
Correlation of a quantitative videocapillaroscopic score with the development of digital skin ulcers in scleroderma patients 260
HHV-6A infection and systemic sclerosis: Clues of a possible association 260
CLINICAL AND PATHOLOGICAL FEATURES OF BREAST CANCER IN PATIENTS WITH SYSTEMIC SCLEROSIS: PRELIMINARY DATA FROM THE SCLERO-BREAST STUDY 258
Autonomic dysfunction in systemic sclerosis: time and frequency domain 24 hour heart rate variability analysis 257
Systemic sclerosis: demographic, clinical, and serologic features and survival in 1,012 Italian patients 257
Systemic sclerosis following human cytomegalovirus infection 256
Insights into the knowledge of complex diseases: Environmental infectious/ toxic agents as potential etiopathogenetic factors of systemic sclerosis 255
Use of Neem oil and Hypericum perforatum for treatment of calcinosis-related skin ulcers in systemic sclerosis 252
Micro and nanoparticles as possible pathogenetic co-factors in mixed cryoglobulinemia 251
UNCLASSIFIABLE INTERSTITIAL LUNG DISEASE OR UNDIFFERENTIATED CONNECTIVE TISSUE DISEASE? A CHALLENGING DIFFERENTIAL DIAGNOSIS 250
HCV-related rheumatic manifestations and therapeutic strategies 249
Parallel increase of circulating CXCL11 and CXCL10 in mixed cryoglobulinemia, while the proinflammatory cytokine IL-6 is associated with high serum Th2 chemokine CCL2 249
Autologous Fat Grafting for the Oral and Digital Complications of Systemic Sclerosis: Results of a Prospective Study 248
Treatment of HCV-related mixed cryoglobulinemia 247
Renal Manifestations of Hepatitis C Virus 247
Validation study of predictive value of capillaroscopic skin ulcer risk index (CSURI) in scleroderma patients treated with bosentan 247
[The alpha chemokine "Interferon gamma-induced protein 10" (IP-10) in Graves' disease and Graves'ophthalmopathy] 246
The safety of iloprost in systemic sclerosis in a real-life experience 246
Clinical and Pathological Features of Breast Cancer in Systemic Sclerosis: Results from the Sclero-Breast Study 246
Measuring microangiopathy abnormalities in systemic sclerosis patients: the role of capillaroscopy-based scoring models 245
Rituximab in the treatment of patients with systemic sclerosis. Our experience and review of the literature 245
Advanced oxidation protein products in serum of patients with systemic sclerosis: a possible indicator of clinical evolution 244
Reactive arthritis induced by intravesical BCG therapy for bladder cancer: our clinical experience and systematic review of the literature 241
Scleroderma Digital Ulcers Complicated by Infection with Fecal Pathogens. 238
Novel Therapies for Thyroid Autoimmune Diseases 236
The treatment of skin ulcers in systemic sclerosis: use of granulocyte-colony stimulating factor (G-CSF) in 26 patients 233
Totale 35.281
Salva come PNG Salva come JPEG
Categoria #
all - tutte 245.541
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 245.541
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.323 0 0 0 0 0 0 0 0 0 526 494 303
2021/20224.403 221 363 353 386 166 334 194 269 463 381 741 532
2022/20235.029 579 419 282 369 592 677 260 478 651 153 324 245
2023/20244.331 184 282 254 492 753 327 363 472 109 237 349 509
2024/202512.041 472 216 243 827 2.233 1.779 830 635 1.329 769 1.254 1.454
2025/202622.216 1.487 901 1.908 3.429 4.661 1.679 2.907 1.147 2.189 1.908 0 0
Totale 65.178